Lufax Regains Compliance with NYSE Listing Standards
Written by Emily J. Thompson, Senior Investment Analyst
Updated: 43 minutes ago
0mins
Should l Buy LU?
Source: PRnewswire
- Compliance Restoration: Lufax received confirmation from the NYSE on April 30, 2026, indicating it has regained compliance with continued listing standards, successfully removing itself from the late filers' list, which enhances investor confidence.
- Financial Reporting Submission: The company timely filed its 2024 20-F report on February 17, 2026, followed by the semi-annual financials for the six-month period ended June 30, 2025 on April 30, ensuring compliance with the SEC and improving transparency.
- Impact of Auditor Change: The delay in report submission was due to a change in auditors, but Lufax successfully obtained an extension from the NYSE through collaboration with Ernst & Young, demonstrating the company's flexibility and adaptability in overcoming challenges.
- Funding Partnerships: Lufax has established long-term partnerships with 87 financial institutions, providing financing products tailored for small business owners, further solidifying its leadership position in China's financial services market and enhancing financing accessibility for small enterprises.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy LU?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on LU
About LU
LUFAX HOLDING LTD is a holding company mainly engaged in providing financial services for small and micro enterprises. The Company's core retail credit enablement business includes bank-funded loans, trust-funded loans and consumer finance loans. The Company is also engaged in wealth management and providing access to financial products and services. The Company conducts the business through its subsidiaries.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
Lufax Regains Compliance with NYSE Listing Standards
- Compliance Restoration: Lufax received confirmation from the NYSE on April 30, 2026, indicating it has regained compliance with continued listing standards, thereby enhancing the company's credibility in the capital markets by being removed from the late filers list.
- Financial Reporting Submission: The company filed its 2024 20-F report on February 17, 2026, within the NYSE's extension period, ensuring compliance with the SEC and avoiding potential fines and sanctions that could arise from non-compliance.
- Impact of Auditor Change: The delay in report submission was due to a change in auditors, but through collaboration with Ernst & Young, Lufax successfully completed the necessary financial audits, which bolstered investor confidence in the company's governance.
- Funding Partnerships: Lufax has established relationships with 87 financial institutions to provide financing products tailored for small business owners, further solidifying its leadership position in the Chinese financial services market.
See More
Lufax Regains Compliance with NYSE Listing Standards
- Compliance Restoration: Lufax received confirmation from the NYSE on April 30, 2026, indicating it has regained compliance with continued listing standards, successfully removing itself from the late filers' list, which enhances investor confidence.
- Financial Reporting Submission: The company timely filed its 2024 20-F report on February 17, 2026, followed by the semi-annual financials for the six-month period ended June 30, 2025 on April 30, ensuring compliance with the SEC and improving transparency.
- Impact of Auditor Change: The delay in report submission was due to a change in auditors, but Lufax successfully obtained an extension from the NYSE through collaboration with Ernst & Young, demonstrating the company's flexibility and adaptability in overcoming challenges.
- Funding Partnerships: Lufax has established long-term partnerships with 87 financial institutions, providing financing products tailored for small business owners, further solidifying its leadership position in China's financial services market and enhancing financing accessibility for small enterprises.
See More
Multiple Companies Facing Class Action Lawsuits
- Class Action Overview: Gemini Space Station, Inc., Power Solutions International, Inc., Hercules Capital, Inc., and Lufax Holding Ltd. are all facing class action lawsuits from investors, who must file lead plaintiff motions by specified deadlines to assert their legal rights.
- Gemini Lawsuit Details: Allegations against Gemini claim that from September 2025 to February 2026, the company overstated the viability of its core business as a crypto platform, leading to inflated post-IPO financial prospects and a potential risk of costly and disruptive restructuring.
- Power Solutions Issues: Power Solutions is accused of failing to disclose its overstated ability to capture sales demand in the data center market from May 2025 to March 2026, including the costs and inefficiencies related to enhancements in manufacturing capacity, rendering its positive statements materially misleading.
- Hercules and Lufax Allegations: Hercules Capital is charged with overstating its due diligence processes, while Lufax faces accusations of inadequate internal controls and materially misstated financial results, both leading to misleading positive statements about their business operations and prospects.
See More
Lufax Faces Class Action Lawsuit Risk
- Class Action Initiated: Robbins LLP has alerted investors that a class action has been filed against Lufax Holding Ltd. (NYSE: LU) for securities purchased between April 7, 2023, and January 26, 2025, highlighting concerns over the company's inadequate internal controls.
- Financial Misstatements: The complaint alleges that Lufax made material misstatements in its financial reports during the class period and lacked adequate internal controls, leading to investor misunderstandings about the company's financial health and impacting investment decisions.
- Auditor Dismissal: On January 27, 2025, Lufax announced the termination of its relationship with PricewaterhouseCoopers due to significant concerns regarding Lufax's financial disclosures, particularly the 2022 and 2023 Annual Reports, which triggered a sharp decline in the company's stock price.
- Stock Price Volatility: Following the auditor dismissal announcement, Lufax's ADS price dropped by 13.8% on January 27, 2025, and continued to decline over the next two days, totaling a loss of over 22%, indicating severe market concerns regarding the company's financial stability.
See More
Reminder of Lufax Securities Class Action
- Class Action Notice: Rosen Law Firm reminds investors who purchased Lufax securities between April 7, 2023, and January 26, 2025, that they must apply to be lead plaintiff by May 20, 2026, to represent other investors in the class action lawsuit.
- Fee Arrangement: Investors joining the Lufax class action will incur no out-of-pocket costs, as the law firm operates on a contingency fee basis, allowing investors to seek compensation without financial burden.
- Lawsuit Background: The lawsuit alleges that Lufax made false and misleading statements during the class period, resulting in investor losses when the true details emerged, highlighting inadequate internal controls and materially misstated financial results.
- Law Firm Credentials: Rosen Law Firm specializes in securities class actions and has achieved the largest settlement against a Chinese company, demonstrating its expertise and success in the field, prompting investors to carefully select experienced legal counsel.
See More
Investor Class Action Lawsuit Reminder
- Lufax Lawsuit Details: Lufax Holding Ltd. (NYSE:LU) is facing a class action lawsuit for failing to disclose inadequate internal controls and misstated financial results during the period from April 7, 2023, to January 26, 2025, with a lead plaintiff deadline of May 20, 2026, which could adversely affect the company's reputation and stock price.
- Atara Biotherapeutics Lawsuit: Atara Biotherapeutics, Inc. (NASDAQ:ATRA) is being sued for undisclosed manufacturing issues and clinical trial risks during the class period from May 20, 2024, to January 9, 2026, requiring lead plaintiff motions by May 22, 2026, potentially jeopardizing future FDA approvals and impacting the company's financial outlook.
- Coty Lawsuit Overview: Coty Inc. (NYSE:COTY) faces a class action lawsuit for underperformance in its Consumer Beauty segment and slowing market growth from November 5, 2025, to February 4, 2026, with a lead plaintiff deadline of May 22, 2026, which may lead to significant financial repercussions for the company.
- Legal Consultation Reminder: The Law Offices of Frank R. Cruz remind investors who suffered losses during the specified periods to contact them for legal advice to protect their rights and mitigate potential financial losses.
See More
Lufax Regains Compliance with NYSE Listing Standards
- Compliance Restoration: Lufax received confirmation from the NYSE on April 30, 2026, indicating it has regained compliance with continued listing standards, thereby enhancing the company's credibility in the capital markets by being removed from the late filers list.
- Financial Reporting Submission: The company filed its 2024 20-F report on February 17, 2026, within the NYSE's extension period, ensuring compliance with the SEC and avoiding potential fines and sanctions that could arise from non-compliance.
- Impact of Auditor Change: The delay in report submission was due to a change in auditors, but through collaboration with Ernst & Young, Lufax successfully completed the necessary financial audits, which bolstered investor confidence in the company's governance.
- Funding Partnerships: Lufax has established relationships with 87 financial institutions to provide financing products tailored for small business owners, further solidifying its leadership position in the Chinese financial services market.
See More
Lufax Regains Compliance with NYSE Listing Standards
- Compliance Restoration: Lufax received confirmation from the NYSE on April 30, 2026, indicating it has regained compliance with continued listing standards, successfully removing itself from the late filers' list, which enhances investor confidence.
- Financial Reporting Submission: The company timely filed its 2024 20-F report on February 17, 2026, followed by the semi-annual financials for the six-month period ended June 30, 2025 on April 30, ensuring compliance with the SEC and improving transparency.
- Impact of Auditor Change: The delay in report submission was due to a change in auditors, but Lufax successfully obtained an extension from the NYSE through collaboration with Ernst & Young, demonstrating the company's flexibility and adaptability in overcoming challenges.
- Funding Partnerships: Lufax has established long-term partnerships with 87 financial institutions, providing financing products tailored for small business owners, further solidifying its leadership position in China's financial services market and enhancing financing accessibility for small enterprises.
See More
Multiple Companies Facing Class Action Lawsuits
- Class Action Overview: Gemini Space Station, Inc., Power Solutions International, Inc., Hercules Capital, Inc., and Lufax Holding Ltd. are all facing class action lawsuits from investors, who must file lead plaintiff motions by specified deadlines to assert their legal rights.
- Gemini Lawsuit Details: Allegations against Gemini claim that from September 2025 to February 2026, the company overstated the viability of its core business as a crypto platform, leading to inflated post-IPO financial prospects and a potential risk of costly and disruptive restructuring.
- Power Solutions Issues: Power Solutions is accused of failing to disclose its overstated ability to capture sales demand in the data center market from May 2025 to March 2026, including the costs and inefficiencies related to enhancements in manufacturing capacity, rendering its positive statements materially misleading.
- Hercules and Lufax Allegations: Hercules Capital is charged with overstating its due diligence processes, while Lufax faces accusations of inadequate internal controls and materially misstated financial results, both leading to misleading positive statements about their business operations and prospects.
See More
Lufax Faces Class Action Lawsuit Risk
- Class Action Initiated: Robbins LLP has alerted investors that a class action has been filed against Lufax Holding Ltd. (NYSE: LU) for securities purchased between April 7, 2023, and January 26, 2025, highlighting concerns over the company's inadequate internal controls.
- Financial Misstatements: The complaint alleges that Lufax made material misstatements in its financial reports during the class period and lacked adequate internal controls, leading to investor misunderstandings about the company's financial health and impacting investment decisions.
- Auditor Dismissal: On January 27, 2025, Lufax announced the termination of its relationship with PricewaterhouseCoopers due to significant concerns regarding Lufax's financial disclosures, particularly the 2022 and 2023 Annual Reports, which triggered a sharp decline in the company's stock price.
- Stock Price Volatility: Following the auditor dismissal announcement, Lufax's ADS price dropped by 13.8% on January 27, 2025, and continued to decline over the next two days, totaling a loss of over 22%, indicating severe market concerns regarding the company's financial stability.
See More
Reminder of Lufax Securities Class Action
- Class Action Notice: Rosen Law Firm reminds investors who purchased Lufax securities between April 7, 2023, and January 26, 2025, that they must apply to be lead plaintiff by May 20, 2026, to represent other investors in the class action lawsuit.
- Fee Arrangement: Investors joining the Lufax class action will incur no out-of-pocket costs, as the law firm operates on a contingency fee basis, allowing investors to seek compensation without financial burden.
- Lawsuit Background: The lawsuit alleges that Lufax made false and misleading statements during the class period, resulting in investor losses when the true details emerged, highlighting inadequate internal controls and materially misstated financial results.
- Law Firm Credentials: Rosen Law Firm specializes in securities class actions and has achieved the largest settlement against a Chinese company, demonstrating its expertise and success in the field, prompting investors to carefully select experienced legal counsel.
See More
Investor Class Action Lawsuit Reminder
- Lufax Lawsuit Details: Lufax Holding Ltd. (NYSE:LU) is facing a class action lawsuit for failing to disclose inadequate internal controls and misstated financial results during the period from April 7, 2023, to January 26, 2025, with a lead plaintiff deadline of May 20, 2026, which could adversely affect the company's reputation and stock price.
- Atara Biotherapeutics Lawsuit: Atara Biotherapeutics, Inc. (NASDAQ:ATRA) is being sued for undisclosed manufacturing issues and clinical trial risks during the class period from May 20, 2024, to January 9, 2026, requiring lead plaintiff motions by May 22, 2026, potentially jeopardizing future FDA approvals and impacting the company's financial outlook.
- Coty Lawsuit Overview: Coty Inc. (NYSE:COTY) faces a class action lawsuit for underperformance in its Consumer Beauty segment and slowing market growth from November 5, 2025, to February 4, 2026, with a lead plaintiff deadline of May 22, 2026, which may lead to significant financial repercussions for the company.
- Legal Consultation Reminder: The Law Offices of Frank R. Cruz remind investors who suffered losses during the specified periods to contact them for legal advice to protect their rights and mitigate potential financial losses.
See More
